These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25701992)

  • 1. Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.
    Fernandes S; Sicuri E; Kayentao K; van Eijk AM; Hill J; Webster J; Were V; Akazili J; Madanitsa M; ter Kuile FO; Hanson K
    Lancet Glob Health; 2015 Mar; 3(3):e143-53. PubMed ID: 25701992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancy.
    Sicuri E; Fernandes S; Macete E; González R; Mombo-Ngoma G; Massougbodgi A; Abdulla S; Kuwawenaruwa A; Katana A; Desai M; Cot M; Ramharter M; Kremsner P; Slustker L; Aponte J; Hanson K; Menéndez C
    PLoS One; 2015; 10(4):e0125072. PubMed ID: 25915616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-based strategies to increase coverage of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in sub-Saharan Africa: a systematic review, meta-analysis, meta-ethnography, and economic assessment.
    Koita K; Kayentao K; Worrall E; Van Eijk AM; Hill J
    Lancet Glob Health; 2024 Sep; 12(9):e1456-e1469. PubMed ID: 39151981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of intermittent preventive treatment with dihydroartemisinin-piperaquine versus single screening and treatment for the control of malaria in pregnancy in Papua, Indonesia: a provider perspective analysis from a cluster-randomised trial.
    Paintain L; Hill J; Ahmed R; Umbu Reku Landuwulang C; Ansariadi A; Rini Poespoprodjo J; Syafruddin D; Khairallah C; Burdam FH; Bonsapia I; Ter Kuile FO; Webster J
    Lancet Glob Health; 2020 Dec; 8(12):e1524-e1533. PubMed ID: 33220216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa.
    Conteh L; Sicuri E; Manzi F; Hutton G; Obonyo B; Tediosi F; Biao P; Masika P; Matovu F; Otieno P; Gosling RD; Hamel M; Odhiambo FO; Grobusch MP; Kremsner PG; Chandramohan D; Aponte JJ; Egan A; Schellenberg D; Macete E; Slutsker L; Newman RD; Alonso P; Menéndez C; Tanner M
    PLoS One; 2010 Jun; 5(6):e10313. PubMed ID: 20559558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact on pregnancy outcomes of intermittent preventive treatment with sulfadoxine-pyrimethamine in urban and peri-urban Papua New Guinea: a retrospective cohort study.
    Cellich P; Unger HW; Rogerson SJ; Mola GDL
    Malar J; 2024 Jul; 23(1):201. PubMed ID: 38970076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing the uptake of Intermittent Preventive Treatment of malaria in pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP) through seasonal malaria chemoprevention channel delivery: protocol of a multicenter cluster randomized implementation trial in Mali and Burkina Faso.
    Koita K; Bognini JD; Agboraw E; Dembélé M; Yabré S; Bihoun B; Coulibaly O; Niangaly H; N'Takpé JB; Lesosky M; Scaramuzzi D; Worrall E; Hill J; Briand V; Tinto H; Kayentao K
    BMC Public Health; 2024 Jan; 24(1):43. PubMed ID: 38166711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of intermittent preventive treatment of malaria in pregnancy in southern Mozambique.
    Sicuri E; Bardají A; Nhampossa T; Maixenchs M; Nhacolo A; Nhalungo D; Alonso PL; Menéndez C
    PLoS One; 2010 Oct; 5(10):e13407. PubMed ID: 20976217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The readiness of malaria services and uptake of intermittent preventive treatment in pregnancy in six sub-Saharan countries.
    Xu X; Liang D; Zhao J; Mpembeni R; Olenja J; Yam EL; Huang J
    J Glob Health; 2024 Jun; 14():04112. PubMed ID: 38939971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region.
    Mikomangwa WP; Oms M; Aklillu E; Kamuhabwa AAR
    BMC Pregnancy Childbirth; 2019 Jul; 19(1):236. PubMed ID: 31286878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual, facility and policy level influences on national coverage estimates for intermittent preventive treatment of malaria in pregnancy in Tanzania.
    Marchant T; Nathan R; Jones C; Mponda H; Bruce J; Sedekia Y; Schellenberg J; Mshinda H; Hanson K
    Malar J; 2008 Dec; 7():260. PubMed ID: 19094198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of monthly intermittent preventive treatment with dihydroartemisinin-piperaquine with and without azithromycin versus monthly sulfadoxine-pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlled trial.
    Madanitsa M; Barsosio HC; Minja DTR; Mtove G; Kavishe RA; Dodd J; Saidi Q; Onyango ED; Otieno K; Wang D; Ashorn U; Hill J; Mukerebe C; Gesase S; Msemo OA; Mwapasa V; Phiri KS; Maleta K; Klein N; Magnussen P; Lusingu JPA; Kariuki S; Mosha JF; Alifrangis M; Hansson H; Schmiegelow C; Gutman JR; Chico RM; Ter Kuile FO
    Lancet; 2023 Mar; 401(10381):1020-1036. PubMed ID: 36913959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of intermittent preventive treatment of malaria in pregnancy and risk factors for maternal anaemia and low birthweight among HIV-negative mothers in Dschang, West region of Cameroon: a cross sectional study.
    Kamga SLS; Ali IM; Ngangnang GR; Ulucesme MC; Keptcheu LTD; Keming EM; Tchuenkam VK; Foyet JV; Aktas M; Noubom M; Payne VK
    Malar J; 2024 Jan; 23(1):6. PubMed ID: 38178125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children.
    Conteh L; Patouillard E; Kweku M; Legood R; Greenwood B; Chandramohan D
    PLoS One; 2010 Aug; 5(8):e12223. PubMed ID: 20808923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The positive effect of malaria IPTp-SP on birthweight is mediated by gestational weight gain but modifiable by maternal carriage of enteric pathogens.
    Waltmann A; McQuade ETR; Chinkhumba J; Operario DJ; Mzembe E; Itoh M; Kayange M; Puerto-Meredith SM; Mathanga DP; Juliano JJ; Carroll I; Bartelt LA; Gutman JR; Meshnick SR
    EBioMedicine; 2022 Mar; 77():103871. PubMed ID: 35217408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting the delivery, access, and use of interventions to prevent malaria in pregnancy in sub-Saharan Africa: a systematic review and meta-analysis.
    Hill J; Hoyt J; van Eijk AM; D'Mello-Guyett L; Ter Kuile FO; Steketee R; Smith H; Webster J
    PLoS Med; 2013; 10(7):e1001488. PubMed ID: 23935459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of malaria during pregnancy: assessing the effect of the distribution of IPTp through the national policy in Benin.
    Le Port A; Cottrell G; Dechavanne C; Briand V; Bouraima A; Guerra J; Choudat I; Massougbodji A; Fayomi B; Migot-Nabias F; Garcia A; Cot M
    Am J Trop Med Hyg; 2011 Feb; 84(2):270-5. PubMed ID: 21292898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi.
    Kapito-Tembo A; Meshnick SR; van Hensbroek MB; Phiri K; Fitzgerald M; Mwapasa V
    J Infect Dis; 2011 Feb; 203(4):464-72. PubMed ID: 21216867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloroquine as weekly chemoprophylaxis or intermittent treatment to prevent malaria in pregnancy in Malawi: a randomised controlled trial.
    Divala TH; Mungwira RG; Mawindo PM; Nyirenda OM; Kanjala M; Ndaferankhande M; Tsirizani LE; Masonga R; Muwalo F; Boudová S; Potter GE; Kennedy J; Goswami J; Wylie BJ; Muehlenbachs A; Ndovie L; Mvula P; Mbilizi Y; Tomoka T; Laufer MK
    Lancet Infect Dis; 2018 Oct; 18(10):1097-1107. PubMed ID: 30195996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and coverage of implementing intermittent preventive treatment of malaria in pregnant women contacting private or public clinics in Tanzania: experience-based viewpoints of health managers in Mkuranga and Mufindi districts.
    Mubyazi GM; Magnussen P; Byskov J; Bloch P
    BMC Health Serv Res; 2013 Oct; 13():372. PubMed ID: 24079911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.